Skip to main content

2021 MIPS Quality Benchmarks

What Are Quality Measure Benchmarks?

When a clinician or group submits measures for the Merit-based Incentive Payment System (MIPS) quality performance category, each measure is assessed against its benchmark to determine how many points the measure earns. In program year 2020, a clinician or group can receive anywhere from 3 to 10 points* for each MIPS measure (not including any bonus points) that meets the data completeness standards and case minimum requirements through Benchmarks. Benchmarks are specific to the collection type: Qualified Clinical Data Registry (QCDR) measures, MIPS Clinical Quality Measures (MIPS CQMs)*, eCQMs, CMS Web Interface measures, the Consumer Assessment of Healthcare Providers and Systems (CAHPS) for MIPS survey, and Part B Claims measures. In order to measure performance that is comparable across the spectrum of performance, benchmarks are established using historical data. Historical benchmarks are based on actual performance data from 2018 that was submitted to the Quality Payment Program (QPP) in 2018.  *MIPS CQMs are measures submitted using registry rules.

How Do Benchmarks Work for Multi-Performance Rate Measures?

Several MIPS quality measures require the collection and submission of data for multiple populations. This means that there can be multiple performance rates associated with a single measure. Historical benchmarks for multi-performance rate measures are created based on an "overall performance rate" (based on a weighted average, simple average or CMS-specified performance rate):

How Are Benchmarks Displayed?

Each benchmark is presented in terms of deciles. Points will be awarded within each decile (see table below). Clinicians who receive a score in the first or second decile will receive 3 points. Clinicians who are in the 3rd decile will receive somewhere between 3 and 3.9 points depending on their exact position in the decile, and clinicians in higher deciles will receive a corresponding number of points. For example, if a clinician submits performance data of 83% on a non-inverse measure, and the 5th decile begins at 72% and the 6th decile begins at 85%, then the clinician will receive between 5 and 5.9 points because 83% is in the 5th decile. For inverse measures where a higher performance is seen by a lower number on the performance score, the scores are reversed in the benchmark deciles (example: Measure 1). An Excel version of the 2021 MIPS Quality Historical Benchmarks can be found here. 

*Measures marked in blue (example: Measure 130) can only earn a maximum score of 7 points.  There are 72 Measures that meet this description.  Topped-out means that the national median performance rate is so high that there is no meaningful difference in performance between clinicians.

Measure Name Measure ID Collection Type Decile 3 Decile 4 Decile 5 Decile 6 Decile 7 Decile 8 Decile 9 Decile 10
Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) 1 MIPS CQM 90.69 - 72.52 72.51 - 55.18 55.17 - 41.99 41.98 - 32.57 32.56 - 25.49 25.48 - 19.16 19.15 - 12.88 <=12.87
Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) 1 eCQM 90.50 - 69.43 69.42 - 53.61 53.6 - 42.12 42.11 - 34.07 34.06 - 28.33 28.32 - 23.57 23.56 - 19.11 <=19.1
Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) 1 Medicare Part B Claims 79.99 - 70.01 70 - 60.01 60 - 50.01 50 - 40.01 40 - 30.01 30 - 20.01 20 - 10.01 <= 10
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) 5 eCQM 1.09 - 65.51 65.52 - 71.94 71.95 - 75.27 75.28 - 78.08 78.09 - 80.46 80.47 - 82.97 82.98 - 86.35 >= 86.36
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) 5 MIPS CQM 90.0 - 95.7 95.71 - 98.01 98.02 - 99.26 99.27 - 99.99 -- -- -- 100
Coronary Artery Disease (CAD): Antiplatelet Therapy 6 MIPS CQM 77.58 - 82.97 82.98 - 86.97 86.98 - 90.34 90.35 - 93.26 93.27 - 95.86 95.87 - 98.93 98.94 - 99.99 100
Coronary Artery Disease (CAD): Beta-Blocker Therapy - Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF < 40%) 7 eCQM 45.83 - 71.56 71.57 - 83.87 83.88 - 88.74 88.75 - 91.78 91.79 - 94.1 94.11 - 95.78 95.79 - 97.74 >= 97.75
Coronary Artery Disease (CAD): Beta-Blocker Therapy - Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF < 40%) 7 MIPS CQM 49.07 - 74.03 74.04 - 84.78 84.79 - 91.92 91.93 - 94.71 94.72 - 97.72 97.73 - 99.99 -- 100
Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) 8 eCQM 86.69 - 90.13 90.14 - 92.3 92.31 - 94.04 94.05 - 95.23 95.24 - 96.36 96.37 - 97.43 97.44 - 99.99 100
Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) 8 MIPS CQM 95.0 - 97.49 97.5 - 99.13 99.14 - 99.99 - 100      
Anti-Depressant Medication Management 9 eCQM 65.38 - 70.68 70.69 - 74.33 74.34 - 78.03 78.04 - 80.94 80.95 - 83.76 83.77 - 86.66 86.67 - 90.55 >= 90.56
Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation 12 eCQM 83.62 - 88.71 88.72 - 92.3 92.31 - 95.05 95.06 - 96.96 96.97 - 98.32 98.33 - 99.28 99.29 - 99.99 100
Age-Related Macular Degeneration (AMD): Dilated Macular Examination 14 Medicare Part B Claims -- -- -- -- 100      
Age-Related Macular Degeneration (AMD): Dilated Macular Examination 14 MIPS CQM 86.18 - 91.74 91.75 - 95.01 95.02 - 96.92 96.93 - 98.51 98.52 - 100      
Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care 19 eCQM 54.33 - 66.66 66.67 - 75.33 75.34 - 81.59 81.6 - 87.17 87.18 - 91.36 91.37 - 95.07 95.08 - 97.87 >= 97.88
Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care 19 MIPS CQM 83.62 - 93.52 93.53 - 97.82 97.83 - 99.92 99.93 - 99.99 100      
Perioperative Care: Selection of Prophylactic Antibiotic - First OR Second-Generation Cephalosporin 21 Medicare Part B Claims -- -- -- -- 100      
Perioperative Care: Selection of Prophylactic Antibiotic - First OR Second-Generation Cephalosporin 21 MIPS CQM 78.79 - 97.5 97.51 - 99.99 -- -- 100      
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) 23 Medicare Part B Claims -- -- -- -- 100      
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) 23 MIPS CQM 95.45 - 99.9 99.91 - 99.99 -- -- 100      
Communication with the Physician or Other Clinician Managing On-Going Care Post-Fracture for Men and Women Aged 50 Years and Older 24 Medicare Part B Claims 79.31 - 94.23 94.24 - 96.07 96.08 - 99.99 -- 100      
Communication with the Physician or Other Clinician Managing On-Going Care Post-Fracture for Men and Women Aged 50 Years and Older 24 MIPS CQM 14.13 - 36.35 36.36 - 78.06 78.07 - 82.87 82.88 - 87.87 87.88 - 93.74 93.75 - 99.79 99.8 - 99.99 100
Screening for Osteoporosis for Women Aged 65-85 Years of Age 39 Medicare Part B Claims 37.13 - 49.56 49.57 - 59.3 59.31 - 66.37 66.38 - 76.02 76.03 - 87.2 87.21 - 96.33 96.34 - 99.99 100
Screening for Osteoporosis for Women Aged 65-85 Years of Age 39 MIPS CQM 13.41 - 28.58 28.59 - 39.79 39.8 - 51.48 51.49 - 61.46 61.47 - 70.34 70.35 - 79.67 79.68 - 90.84 >= 90.85
Coronary Artery Bypass Graft (CABG): Preoperative Beta-Blocker in Patients with Isolated CABG Surgery 44 MIPS CQM 94.29 - 96.5 96.51 - 98.56 98.57 - 99.99 -- 100      
Advance Care Plan 47 Medicare Part B Claims 84.39 - 97.45 97.46 - 99.69 99.7 - 99.99 -- 100      
Advance Care Plan 47 MIPS CQM 20.33 - 43.83 43.84 - 64.43 64.44 - 79.01 79.02 - 89.23 89.24 - 95.59 95.6 - 98.94 98.95 - 99.99 100
Urinary Incontinence: Assessment of Presence or Absence of Urinary Incontinence in Women Aged 65 Years and Older 48 MIPS CQM 23.56 - 40.06 40.07 - 57.37 57.38 - 73.74 73.75 - 82.38 82.39 - 93.04 93.05 - 98.53 98.54 - 99.99 100
Urinary Incontinence: Plan of Care for Urinary Incontinence in Women Aged 65 Years and Older 50 Medicare Part B Claims 97.56 - 99.99 -- -- -- 100      
Urinary Incontinence: Plan of Care for Urinary Incontinence in Women Aged 65 Years and Older 50 MIPS CQM 57.62 - 74.65 74.66 - 84.45 84.46 - 90.27 90.28 - 95.85 95.86 - 99.84 99.85 - 99.99 -- 100
Chronic Obstructive Pulmonary Disease (COPD): Long-Acting Inhaled Bronchodilator Therapy 52 MIPS CQM 84.62 - 94.99 95.0 - 98.28 98.29 - 99.66 99.67 - 99.99 100      
Appropriate Treatment for Children with Upper Respiratory Infection (URI) 65 eCQM 76.15 - 80.78 80.79 - 84.38 84.39 - 87.09 87.1 - 90.1 90.11 - 92.85 92.86 - 95.57 95.58 - 99.99 100
Appropriate Treatment for Children with Upper Respiratory Infection (URI) 65 MIPS CQM 93.33 - 95.44 95.45 - 97.13 97.14 - 98.43 98.44 - 99.4 99.41 - 100      
Appropriate Testing for Children with Pharyngitis 66 eCQM 52.34 - 67.15 67.16 - 76.07 76.08 - 81.74 81.75 - 85.52 85.53 - 87.83 87.84 - 90.68 90.69 - 94.45 >= 94.46
Appropriate Testing for Children with Pharyngitis 66 MIPS CQM 80.85 - 88.08 88.09 - 93.09 93.1 - 97.1 97.11 - 99.99 -- -- -- 100
Hematology: Myelodysplastic Syndrome (MDS) and Acute Leukemias: Baseline Cytogenetic Testing Performed on Bone Marrow 67 MIPS CQM 96.41 - 99.99 -- -- -- -- -- -- 100
Hematology: Chronic Lymphocytic Leukemia (CLL): Baseline Flow Cytometry 70 MIPS CQM 64.44 - 98.45 98.46 - 99.99 -- -- -- -- -- 100
Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections 76 Medicare Part B Claims 99.7 - 99.99 -- -- -- 100      
Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections 76 MIPS CQM 97.2 - 99.42 99.43 - 99.99 -- -- 100      
Acute Otitis Externa (AOE): Systemic Antimicrobial Therapy - Avoidance of Inappropriate Use 93 Medicare Part B Claims 93.55 - 96.29 96.3 - 98.1 98.11 - 99.99 -- 100      
Acute Otitis Externa (AOE): Systemic Antimicrobial Therapy - Avoidance of Inappropriate Use 93 MIPS CQM 83.89 - 89.45 89.46 - 92.85 92.86 - 95.51 95.52 - 97.25 97.26 - 100      
Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients 102 eCQM -- -- -- -- -- -- -- --
Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients 102 MIPS CQM 90.61 - 97.11 97.12 - 99.99 -- -- 100      
Prostate Cancer: Combination Androgen Deprivation Therapy for High Risk or Very High Risk Prostate Cancer 104 MIPS CQM 95.85 - 99.6 99.61 - 99.99 -- -- 100      
Adult Major Depressive Disorder (MDD): Suicide Risk Assessment 107 eCQM 2.04 - 4.75 4.76 - 10.47 10.48 - 22.12 22.13 - 37.6 37.61 - 57.22 57.23 - 72.48 72.49 - 92.61 >= 92.62
Preventive Care and Screening: Influenza Immunization 110 Medicare Part B Claims -- -- -- -- -- -- -- --
Preventive Care and Screening: Influenza Immunization 110 eCQM -- -- -- -- -- -- -- --
Preventive Care and Screening: Influenza Immunization 110 MIPS CQM -- -- -- -- -- -- -- --
Pneumococcal Vaccination Status for Older Adults 111 Medicare Part B Claims 68.68 - 76.31 76.32 - 82.46 82.47 - 87.56 87.57 - 93.08 93.09 - 97.89 97.9 - 99.99 -- 100
Pneumococcal Vaccination Status for Older Adults 111 eCQM 20.44 - 33.71 33.72 - 44.69 44.7 - 54.85 54.86 - 63.21 63.22 - 71.09 71.1 - 78.79 78.8 - 87.92 >= 87.93
Pneumococcal Vaccination Status for Older Adults 111 MIPS CQM 35.11 - 51.28 51.29 - 61.89 61.9 - 69.15 69.16 - 74.99 75.0 - 79.89 79.9 - 85.82 85.83 - 94.99 >= 95.0
Breast Cancer Screening 112 Medicare Part B Claims 66.67 - 77.07 77.08 - 84.87 84.88 - 89.62 89.63 - 93.47 93.48 - 97.35 97.36 - 99.02 99.03 - 99.99 100
Breast Cancer Screening 112 eCQM 24.44 - 37.13 37.14 - 46.31 46.32 - 54.4 54.41 - 61.1 61.11 - 67.22 67.23 - 73.94 73.95 - 82.01 >= 82.02
Breast Cancer Screening 112 MIPS CQM 22.37 - 39.99 40.0 - 50.97 50.98 - 60.26 60.27 - 70.2 70.21 - 78.1 78.11 - 85.84 85.85 - 97.35 >= 97.36
Colorectal Cancer Screening 113 Medicare Part B Claims -- -- -- -- -- -- -- --
Colorectal Cancer Screening 113 eCQM 15.15 - 27.51 27.52 - 38.73 38.74 - 49.04 49.05 - 58.3 58.31 - 67.54 67.55 - 76.05 76.06 - 85.05 >= 85.06
Colorectal Cancer Screening 113 MIPS CQM -- -- -- -- -- -- -- --
Avoidance of Antibiotic Treatment in Adults With Acute Bronchitis 116 MIPS CQM 62.33 - 75.99 76.0 - 86.35 86.36 - 93.32 93.33 - 96.91 96.92 - 98.42 98.43 - 99.99 -- 100
Diabetes: Eye Exam 117 Medicare Part B Claims 97.83 - 99.99 -- -- -- 100      
Diabetes: Eye Exam 117 eCQM 12.0 - 20.54 20.55 - 30.68 30.69 - 44.81 44.82 - 69.39 69.4 - 94.16 94.17 - 98.42 98.43 - 99.92 >= 99.93
Diabetes: Eye Exam 117 MIPS CQM 89.93 - 96.67 96.68 - 98.85 98.86 - 99.69 99.7 - 99.99 100      
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%) 118 MIPS CQM 72.73 - 76.31 76.32 - 79.6 79.61 - 81.84 81.85 - 84.99 85.0 - 86.82 86.83 - 90.47 90.48 - 95.99 >= 96.0
Diabetes: Medical Attention for Nephropathy 119 eCQM 70.31 - 76.91 76.92 - 81.54 81.55 - 85.22 85.23 - 88.23 88.24 - 91.4 91.41 - 94.77 94.78 - 98.54 >= 98.55
Diabetes: Medical Attention for Nephropathy 119 MIPS CQM 71.17 - 79.47 79.48 - 86.66 86.67 - 91.8 91.81 - 96.22 96.23 - 98.67 98.68 - 99.99 -- 100
Diabetes Mellitus: Diabetic Foot and Ankle Care, Peripheral Neuropathy - Neurological Evaluation 126 MIPS CQM 59.55 - 74.75 74.76 - 86.48 86.49 - 94.86 94.87 - 99.31 99.32 - 99.99 -- -- 100
Diabetes Mellitus: Diabetic Foot and Ankle Care, Ulcer Prevention - Evaluation of Footwear 127 MIPS CQM 58.76 - 74.02 74.03 - 85.05 85.07 - 94.64 94.65 - 99.17 99.18 - 99.99 -- -- 100
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan 128 Medicare Part B Claims 91.47 - 98.57 98.58 - 99.72 99.73 - 99.99 -- 100      
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan 128 eCQM 23.26 - 27.41 27.42 - 32.64 32.65 - 40.9 40.91 - 53.42 53.43 - 69.26 69.27 - 83.79 83.8 - 95.11 >= 95.12
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan 128 MIPS CQM 32.73 - 51.05 51.06 - 70.16 70.17 - 84.68 84.69 - 93.27 93.28 - 98.05 98.06 - 99.75 99.76 - 99.99 100
Documentation of Current Medications in the Medical Record 130 Medicare Part B Claims 99.67 - 99.93 99.94 - 99.99 -- -- 100      
Documentation of Current Medications in the Medical Record 130 eCQM 83.73 - 91.27 91.28 - 94.9 94.91 - 96.99 97.0 - 98.3 98.31 - 100      
Documentation of Current Medications in the Medical Record 130 MIPS CQM 86.71 - 96.31 96.32 - 98.94 98.95 - 99.67 99.68 - 99.9 99.91 - 100      
Preventive Care and Screening: Screening for Depression and Follow-Up Plan 134 Medicare Part B Claims 95.94 - 99.5 99.51 - 99.99 -- -- 100      
Preventive Care and Screening: Screening for Depression and Follow-Up Plan 134 eCQM -- -- -- -- -- -- -- --
Preventive Care and Screening: Screening for Depression and Follow-Up Plan 134 MIPS CQM 14.76 - 37.43 37.44 - 55.92 55.93 - 71.73 71.74 - 84.68 84.69 - 95.55 95.56 - 99.21 99.22 - 99.99 100
Melanoma: Continuity of Care - Recall System 137 MIPS CQM 95.0 - 98.83 98.84 - 99.99 -- -- -- -- -- 100
Melanoma: Coordination of Care 138 MIPS CQM 75.51 - 92.58 92.59 - 98.8 98.81 - 99.99 -- 100      
Primary Open-Angle Glaucoma (POAG): Reduction of Intraocular Pressure (IOP) by 15% OR Documentation of a Plan of Care 141 Medicare Part B Claims -- -- -- -- -- -- -- 100
Primary Open-Angle Glaucoma (POAG): Reduction of Intraocular Pressure (IOP) by 15% OR Documentation of a Plan of Care 141 MIPS CQM 32.62 - 60.31 60.32 - 82.13 82.14 - 93.47 93.48 - 98.54 98.55 - 99.99 -- -- 100
Oncology: Medical and Radiation - Pain Intensity Quantified 143 eCQM 67.56 - 85.31 85.32 - 91.88 91.89 - 95.33 95.34 - 97.06 97.07 - 97.95 97.96 - 98.79 98.8 - 99.8 >= 99.81
Oncology: Medical and Radiation - Pain Intensity Quantified 143 MIPS CQM 93.65 - 97.65 97.66 - 99.2 99.21 - 99.83 99.84 - 99.99 100      
Oncology: Medical and Radiation – Plan of Care for Pain 144 MIPS CQM -- -- -- -- -- -- -- --
Radiology: Exposure Dose Indices or Exposure Time and Number of Images Reported for Procedures Using Fluoroscopy 145 Medicare Part B Claims 85.71 - 94.43 94.44 - 97.61 97.62 - 99.18 99.19 - 99.99 100      
Radiology: Exposure Dose Indices or Exposure Time and Number of Images Reported for Procedures Using Fluoroscopy 145 MIPS CQM 86.61 - 95.47 95.48 - 98.4 98.41 - 99.72 99.73 - 99.99 100      
Nuclear Medicine: Correlation with Existing Imaging Studies for All Patients Undergoing Bone Scintigraphy 147 Medicare Part B Claims 71.43 - 85.7 85.71 - 95.44 95.45 - 98.45 98.46 - 99.99 100      
Nuclear Medicine: Correlation with Existing Imaging Studies for All Patients Undergoing Bone Scintigraphy 147 MIPS CQM 93.66 - 98.91 98.92 - 99.99 -- -- 100      
Falls: Risk Assessment 154 Medicare Part B Claims 99.07 - 99.99 -- -- -- 100      
Falls: Risk Assessment 154 MIPS CQM 87.86 - 96.12 96.13 - 98.81 98.82 - 99.99 -- 100      
Falls: Plan of Care 155 Medicare Part B Claims 87.5 - 98.07 98.08 - 99.99 -- -- 100      
Falls: Plan of Care 155 MIPS CQM 85.88 - 93.87 93.88 - 97.83 97.84 - 99.99 -- -- -- -- 100
Coronary Artery Bypass Graft (CABG): Prolonged Intubation 164 MIPS CQM 8.8 - 7.7 7.69 - 5.88 5.87 - 5.01 5.0 - 3.53 3.52 - 2.64 2.63 - 1.6 1.59 - 0.01 0
Coronary Artery Bypass Graft (CABG): Postoperative Renal Failure 167 MIPS CQM 3.6 - 2.45 2.44 - 2.05 2.04 - 1.48 1.47 - 1.23 1.22 - 0.56 0.55 - 0.01 -- 0
Coronary Artery Bypass Graft (CABG): Surgical Re-Exploration 168 MIPS CQM 3.04 - 2.49 2.48 - 2.15 2.14 - 1.56 1.55 - 1.22 1.21 - 0.49 0.48 - 0.01 -- 0
Rheumatoid Arthritis (RA): Tuberculosis Screening 176 MIPS CQM 51.61 - 77.62 77.63 - 89.7 89.71 - 93.19 93.2 - 97.36 97.37 - 99.99 -- -- 100
Rheumatoid Arthritis (RA): Periodic Assessment of Disease Activity 177 MIPS CQM 65.49 - 75.19 75.2 - 85.37 85.38 - 91.03 91.04 - 95.21 95.22 - 98.22 98.23 - 99.66 99.67 - 99.99 100
Rheumatoid Arthritis (RA): Functional Status Assessment 178 MIPS CQM 76.28 - 89.39 89.4 - 94.25 94.26 - 97.71 97.72 - 99.02 99.03 - 100      
Rheumatoid Arthritis (RA): Glucocorticoid Management 180 MIPS CQM 98.26 - 99.68 99.69 - 99.99 -- -- -- -- -- 100
Elder Maltreatment Screen and Follow-Up Plan 181 Medicare Part B Claims 98.88 - 99.99 -- -- -- 100      
Elder Maltreatment Screen and Follow-Up Plan 181 MIPS CQM 58.52 - 78.65 78.66 - 89.12 89.13 - 95.65 95.66 - 98.91 98.92 - 99.99 -- -- 100
Functional Outcome Assessment 182 Medicare Part B Claims 99.56 - 99.99 -- -- -- 100      
Functional Outcome Assessment 182 MIPS CQM 98.57 - 99.58 99.59 - 99.83 99.84 - 99.99 -- -- -- -- 100
Colonoscopy Interval for Patients with a History of Adenomatous Polyps - Avoidance of Inappropriate Use 185 MIPS CQM 44.62 - 81.24 81.25 - 90.58 90.59 - 95.73 95.74 - 98.04 98.05 - 99.54 99.55 - 99.99 -- 100
Stroke and Stroke Rehabilitation: Thrombolytic Therapy 187 MIPS CQM 82.74 - 88.31 88.32 - 91.66 91.67 - 93.54 93.55 - 95.44 95.45-100      
Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery 191 eCQM 88.04 - 93.45 93.46 - 95.7 95.71 - 97.12 97.13 - 98.22 98.23 - 98.85 98.86 - 99.49 99.5 - 99.99 100
Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery 191 MIPS CQM 94.17 - 96.29 96.3 - 97.43 97.44 - 98.44 98.45 - 99.44 99.45 - 99.99 -- -- 100
Radiology: Stenosis Measurement in Carotid Imaging Reports 195 Medicare Part B Claims 97.77 - 99.39 99.4 - 99.99 -- -- 100      
Radiology: Stenosis Measurement in Carotid Imaging Reports 195 MIPS CQM 99.28 - 99.83 99.84 - 99.99 -- -- 100      
HIV/AIDS: Sexually Transmitted Disease Screening for Chlamydia, Gonorrhea, and Syphilis 205 MIPS CQM -- -- -- -- -- -- -- --
Functional Status Change for Patients with Knee Impairments 217 MIPS CQM -- -- -- -- -- -- -- --
Functional Status Change for Patients with Hip Impairments 218 MIPS CQM -- -- -- -- -- -- -- --
Functional Status Change for Patients with Lower Leg, Foot or Ankle Impairments 219 MIPS CQM -- -- -- -- -- -- -- --
Functional Status Change for Patients with Low Back Impairments 220 MIPS CQM -- -- -- -- -- -- -- --
Functional Status Change for Patients with Shoulder Impairments 221 MIPS CQM -- -- -- -- -- -- -- --
Functional Status Change for Patients with Elbow, Wrist or Hand Impairments 222 MIPS CQM -- -- -- -- -- -- -- --
Radiology: Reminder System for Screening Mammograms 225 Medicare Part B Claims -- -- -- -- -- -- -- 100
Radiology: Reminder System for Screening Mammograms 225 MIPS CQM -- -- -- -- -- -- -- 100
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 226 Medicare Part B Claims -- -- -- -- -- -- -- --
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 226 eCQM -- -- -- -- -- -- -- --
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 226 MIPS CQM -- -- -- -- -- -- -- --
Controlling High Blood Pressure 236 Medicare Part B Claims 20 - 29.99 30 - 39.99 40 - 49.99 50 - 59.99 60 - 69.99 70 - 79.99 80 - 89.99 >= 90
Controlling High Blood Pressure 236 MIPS CQM 20 - 29.99 30 - 39.99 40 - 49.99 50 - 59.99 60 - 69.99 70 - 79.99 80 - 89.99 >= 90
Controlling High Blood Pressure 236 eCQM 51.69 - 57.07 57.08 - 61.32 61.33 - 64.79 64.8 - 68.44 68.45 - 72.03 72.04 - 76.35 76.36 - 82.37 >= 82.38
Use of High-Risk Medications in the Elderly 238 MIPS CQM -- -- -- -- -- -- -- --
Use of High-Risk Medications in the Elderly 238 eCQM -- -- -- -- -- -- -- --
Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents 239 eCQM 27.47 - 30.48 30.49 - 32.12 32.13 - 33.32 33.33 - 34.47 34.48 - 38.53 38.54 - 47.92 47.93 - 63.64 >= 63.65
Childhood Immunization Status 240 eCQM 17.93 - 25.53 25.54 - 32.39 32.4 - 36.74 36.75 - 40.18 40.19 - 44.73 44.74 - 49.56 49.57 - 56.85 >= 56.86
Cardiac Rehabilitation Patient Referral from an Outpatient Setting 243 MIPS CQM 19.02 - 25.63 25.64 - 31.42 31.43 - 37.13 37.14 - 42.85 42.86 - 48.97 48.98 - 63.7 63.71 - 90.57 >= 90.58
Barrett's Esophagus 249 Medicare Part B Claims -- -- -- -- 100      
Barrett's Esophagus 249 MIPS CQM -- -- -- -- 100      
Radical Prostatectomy Pathology Reporting 250 Medicare Part B Claims -- -- -- -- 100      
Radical Prostatectomy Pathology Reporting 250 MIPS CQM -- -- -- -- 100      
Ultrasound Determination of Pregnancy Location for Pregnant Patients with Abdominal Pain 254 Medicare Part B Claims -- -- -- -- -- -- -- --
Ultrasound Determination of Pregnancy Location for Pregnant Patients with Abdominal Pain 254 MIPS CQM 88.64 - 92.24 92.25 - 95.25 95.26 - 96.76 96.77 - 98.24 98.25-100      
Rate of Open Repair of Small or Moderate Non-Ruptured Infrarenal Abdominal Aortic Aneurysms (AAA) without Major Complications (Discharged to Home by Post-Operative Day #7) 258 MIPS CQM -- -- -- -- -- -- -- --
Rate of Endovascular Aneurysm Repair (EVAR) of Small or Moderate Non-Ruptured Infrarenal Abdominal Aortic Aneurysms (AAA) without Major Complications (Discharged to Home by Post Operative Day #2) 259 MIPS CQM -- -- -- -- -- -- -- --
Rate of Carotid Endarterectomy (CEA) for Asymptomatic Patients, without Major Complications (Discharged to Home by Post-Operative Day #2) 260 MIPS CQM -- -- -- -- -- -- -- --
Referral for Otologic Evaluation for Patients with Acute or Chronic Dizziness 261 Medicare Part B Claims -- -- -- -- -- -- -- --
Referral for Otologic Evaluation for Patients with Acute or Chronic Dizziness 261 MIPS CQM -- -- -- -- -- -- -- --
Sentinel Lymph Node Biopsy for Invasive Breast Cancer 264 MIPS CQM -- -- -- -- -- -- -- --
Biopsy Follow-Up 265 MIPS CQM 78.39 - 95.4 95.41 - 99.07 99.08 - 99.99 -- 100      
Epilepsy: Counseling for Women of Childbearing Potential with Epilepsy 268 MIPS CQM 14.49 - 23.99 24.0 - 39.21 39.22 - 49.99 50.0 - 65.47 65.48 - 89.49 89.5 - 94.99 95.0 - 99.99 100
Inflammatory Bowel Disease (IBD): Assessment of Hepatitis B Virus (HBV) Status Before Initiating Anti-TNF (Tumor Necrosis Factor) Therapy 275 MIPS CQM -- -- -- -- -- -- -- --
Sleep Apnea: Severity Assessment at Initial Diagnosis 277 MIPS CQM 24.0 - 42.79 42.8 - 58.22 58.23 - 71.64 71.65 - 93.09 93.1 - 99.86 99.87 - 99.99 -- 100
Sleep Apnea: Assessment of Adherence to Positive Airway Pressure Therapy 279 MIPS CQM 88.15 - 95.64 95.65 - 98.68 98.69 - 99.99 -- 100      
Dementia: Cognitive Assessment 281 eCQM 8.33 - 13.63 13.64 - 21.73 21.74 - 31.57 31.58 - 44.82 44.83 - 59.73 59.74 - 73.9 73.91 - 91.88 >= 91.89
Dementia: Functional Status Assessment 282 MIPS CQM 43.54 - 68.17 68.18 - 91.03 91.04 - 98.23 98.24 - 99.99 -- -- -- 100
Dementia Associated Behavioral and Psychiatric Symptoms Screening and Management 283 MIPS CQM 75.0 - 92.44 92.45 - 96.36 96.37 - 98.67 98.68 - 99.99 100      
Dementia: Safety Concern Screening and Follow-Up for Patients with Dementia 286 MIPS CQM 86.36 - 93.37 93.38 - 97.66 97.67 - 99.99 -- 100      
Dementia: Education and Support of Caregivers for Patients with Dementia 288 MIPS CQM 43.28 - 66.66 66.67 - 83.32 83.33 - 95.38 95.39 - 98.32 98.33 - 99.99 -- -- 100
Parkinson's Disease: Psychiatric Symptoms Assessment for Patients with Parkinson's Disease 290 MIPS CQM 34.39 - 57.46 57.47 - 81.07 81.08 - 92.05 92.06 - 98.05 98.06 - 99.99 -- -- 100
Parkinson's Disease: Cognitive Impairment or Dysfunction Assessment for Patients with Parkinson's Disease 291 MIPS CQM 25.57 - 59.88 59.89 - 89.27 89.28 - 98.93 98.94 - 99.99 100      
Parkinson's Disease: Rehabilitative Therapy Options 293 MIPS CQM 48.35 - 65.7 65.71 - 85.7 85.71 - 93.72 93.73 - 99.99 100      
Cataracts: Improvement in Patient's Visual Function within 90 Days Following Cataract Surgery 303 MIPS CQM -- -- -- -- -- -- -- --
Cataracts: Patient Satisfaction within 90 Days Following Cataract Surgery 304 MIPS CQM -- -- -- -- -- -- -- --
Initiation and Engagement of Alcohol and Other Drug Dependence Treatment 305 eCQM 0.27 - 0.42 0.43 - 0.63 0.64 - 0.91 0.92 - 1.24 1.25 - 1.84 1.85 - 2.9 2.91 - 7.64 >= 7.65
Cervical Cancer Screening 309 eCQM 11.36 - 18.36 18.37 - 24.99 25.0 - 32.28 32.29 - 39.56 39.57 - 46.8 46.81 - 55.55 55.56 - 68.16 >= 68.17
Chlamydia Screening for Women 310 eCQM 19.88 - 26.66 26.67 - 32.19 32.2 - 37.65 37.66 - 42.46 42.47 - 47.49 47.5 - 56.06 56.07 - 65.96 >= 65.97
Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented 317 Medicare Part B Claims -- -- -- -- -- -- -- --
Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented 317 eCQM -- -- -- -- -- -- -- --
Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented 317 MIPS CQM -- -- -- -- -- -- -- --
Falls: Screening for Future Fall Risk 318 eCQM 18.81 - 36.27 36.28 - 52.33 52.34 - 66.64 66.65 - 78.71 78.72 - 87.49 87.5 - 94.18 94.19 - 98.26 >= 98.27
Appropriate Follow-Up Interval for Normal Colonoscopy in Average Risk Patients 320 Medicare Part B Claims 92.68 - 99.06 99.07 - 99.99 -- -- 100      
Appropriate Follow-Up Interval for Normal Colonoscopy in Average Risk Patients 320 MIPS CQM 81.69 - 89.01 89.02 - 93.29 93.3 - 95.8 95.81 - 97.46 97.47 - 100      
Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low-Risk Surgery Patients 322 MIPS CQM 0.33 - 0.01 -- -- -- -- -- -- 0
Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Routine Testing After Percutaneous Coronary Intervention (PCI) 323 MIPS CQM -- -- -- -- -- -- -- 0
Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Testing in Asymptomatic, Low-Risk Patients 324 MIPS CQM 2.51 - 0.72 0.71 - 0.01 -- -- -- -- -- 0
Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy 326 Medicare Part B Claims 98.63 - 99.99 -- -- -- 100      
Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy 326 MIPS CQM 79.1 - 83.67 83.68 - 88.45 88.46 - 94.5 94.51 - 98.7 98.71 - 100      
Adult Sinusitis: Antibiotic Prescribed for Acute Viral Sinusitis (Overuse) 331 MIPS CQM 75.95 - 62.51 62.5 - 50.13 50.12 - 37.58 37.57 - 25.13 25.12 - 14.82 14.81 - 5.29 5.28 - 0.01 0
Adult Sinusitis: Appropriate Choice of Antibiotic: Amoxicillin With or Without Clavulanate Prescribed for Patients with Acute Bacterial Sinusitis (Appropriate Use) 332 MIPS CQM 52.44 - 61.36 61.37 - 72.63 72.64 - 85.75 85.76 - 89.93 89.94 - 96.12 96.13 - 99.99 -- 100
Maternity Care: Elective Delivery or Early Induction Without Medical Indication at < 39 Weeks (Overuse) 335 MIPS CQM -- -- -- -- -- -- -- --
Maternity Care: Postpartum Follow-up and Care Coordination 336 MIPS CQM -- -- -- -- -- -- -- --
Psoriasis: Tuberculosis (TB) Prevention for Patients with Psoriasis, Psoriatic Arthritis and Rheumatoid Arthritis on a Biological Immune Response Modifier 337 MIPS CQM 68.0 - 80.76 80.77 - 88.88 88.89 - 94.41 94.42 - 97.53 97.54 - 99.99 -- -- 100
HIV Viral Load Suppression 338 MIPS CQM 76.89 - 84.2 84.21 - 87.32 87.33 - 91.54 91.55 - 95.36 95.37 - 96.96 96.97 - 99.99 -- 100
HIV Medical Visit Frequency 340 MIPS CQM 54.8 - 60.08 60.09 - 69.99 70.0 - 74.99 75.0 - 84.5 84.51 - 98.47 98.48 - 99.99 -- 100
Pain Brought Under Control Within 48 Hours 342 MIPS CQM -- -- -- -- -- -- -- 100
Rate of Carotid Artery Stenting (CAS) for Asymptomatic Patients, Without Major Complications (Discharged to Home by Post-Operative Day #2) 344 MIPS CQM -- -- -- -- -- -- -- --
Total Knee Replacement: Shared Decision-Making: Trial of Conservative (Non-surgical) Therapy 350 MIPS CQM 99.6 - 99.99 -- -- -- 100      
Total Knee Replacement: Venous Thromboembolic and Cardiovascular Risk Evaluation 351 MIPS CQM 99.36 - 99.99 -- -- -- 100      
Anastomotic Leak Intervention 354 MIPS CQM 3.23 - 1.8 1.79 - 0.01 -- -- -- -- -- 0
Unplanned Reoperation within the 30 Day Postoperative Period 355 MIPS CQM 2.45 - 1.34 1.33 - 0.8 0.79 - 0.19 0.18 - 0.01 -- -- -- 0
Unplanned Hospital Readmission within 30 Days of Principal Procedure 356 MIPS CQM 5.76 - 3.96 3.95 - 2.79 2.78 - 1.1 1.09 - 0.01 -- -- -- 0
Surgical Site Infection (SSI) 357 MIPS CQM 3.33 - 1.83 1.82 - 0.78 0.77 - 0.01 -- -- -- -- 0
Patient-Centered Surgical Risk Assessment and Communication 358 MIPS CQM 34.62 - 72.42 72.43 - 91.22 91.23 - 98.5 98.51 - 99.99 -- -- -- 100
Optimizing Patient Exposure to Ionizing Radiation: Count of Potential High Dose Radiation Imaging Studies: Computed Tomography (CT) and Cardiac Nuclear Medicine Studies 360 MIPS CQM 85.51 - 98.76 98.77 - 99.93 99.94 - 99.99 -- 100      
Optimizing Patient Exposure to Ionizing Radiation: Appropriateness: Follow-up CT Imaging for Incidentally Detected Pulmonary Nodules According to Recommended Guidelines 364 MIPS CQM 95.83 - 98.1 98.11 - 99.99 -- -- -- -- -- 100
Follow-Up Care for Children Prescribed ADHD Medication (ADD) 366 eCQM 20.31 - 24.13 24.14 - 29.54 29.55 - 35.94 35.95 - 39.52 39.53 - 45.48 45.49 - 50.58 50.59 - 65.63 >= 65.64
Depression Remission at Twelve Months 370 MIPS CQM -- -- -- -- -- -- -- --
Depression Remission at Twelve Months 370 eCQM 3.65 - 4.91 4.92 - 6.33 6.34 - 7.6 7.61 - 9.62 9.63 - 11.99 12.0 - 14.99 15 - 22.02 >= 22.03
Closing the Referral Loop: Receipt of Specialist Report 374 eCQM 9.72 - 16.97 16.98 - 25.5 25.51 - 34.92 34.93 - 46.42 46.43 - 59.99 60.0 - 74.59 74.6 - 89.65 >= 89.66
Closing the Referral Loop: Receipt of Specialist Report 374 MIPS CQM 60.0 - 77.54 77.55 - 92.3 92.31 - 97.54 97.55 - 99.99 -- -- -- 100
Functional Status Assessment for Total Knee Replacement 375 eCQM 8.19 - 10.31 10.32 - 14.83 14.84 - 21.09 21.1 - 29.08 29.09 - 37.49 37.5 - 51.34 51.35 - 61.02 >= 61.03
Functional Status Assessment for Total Hip Replacement 376 eCQM 4.73 - 8.32 8.33 - 11.53 11.54 - 15.82 15.83 - 19.74 19.75 - 33.32 33.33 - 53.56 53.57 - 99.99 100
Functional Status Assessments for Congestive Heart Failure 377 eCQM -- -- -- -- -- -- -- --
Children Who Have Dental Decay or Cavities 378 eCQM 0.87 - 0.39 0.38 - 0.01 -- -- -- -- -- 0
Primary Caries Prevention Intervention as Offered by Primary Care Providers, including Dentists 379 eCQM 0.26 - 0.53 0.54 - 1.09 1.1 - 2.18 2.19 - 3.84 3.85 - 5.22 5.23 - 7.3 7.31 - 13.66 >= 13.67
Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment 382 eCQM 7.45 - 12.49 12.5 - 19.11 19.12 - 29.79 29.8 - 39.08 39.09 - 47.1 47.11 - 58.7 58.71 - 87.46 >= 87.47
Adherence to Antipsychotic Medications For Individuals with Schizophrenia 383 MIPS CQM 51.52 - 80.84 80.85 - 96.51 96.52 - 99.99 -- -- -- -- 100
Adult Primary Rhegmatogenous Retinal Detachment Surgery: No Return to the Operating Room Within 90 Days of Surgery 384 MIPS CQM 96.0 - 99.99 -- -- -- -- -- -- 100
Adult Primary Rhegmatogenous Retinal Detachment Surgery: Visual Acuity Improvement Within 90 Days of Surgery 385 MIPS CQM -- -- -- -- -- -- -- --
Amyotrophic Lateral Sclerosis (ALS) Patient Care Preferences 386 MIPS CQM -- -- -- -- -- -- -- --
Annual Hepatitis C Virus (HCV) Screening for Patients who are Active Injection Drug Users 387 MIPS CQM -- -- -- -- -- -- -- --
Cataract Surgery: Difference Between Planned and Final Refraction 389 MIPS CQM 30.48 - 38.53 38.54 - 51.94 51.95 - 71.07 71.08 - 94.45 94.46 - 98.18 98.19 - 99.99 -- 100
Follow-Up After Hospitalization for Mental Illness (FUH) 391 MIPS CQM -- -- -- -- -- -- -- --
Cardiac Tamponade and/or Pericardiocentesis Following Atrial Fibrillation Ablation 392 MIPS CQM -- -- -- -- -- -- -- --
Infection within 180 Days of Cardiac Implantable Electronic Device (CIED) Implantation, Replacement, or Revision 393 MIPS CQM -- -- -- -- -- -- -- --
Immunizations for Adolescents 394 MIPS CQM 3.28 - 7.68 7.69 - 18.58 18.59 - 22.72 22.73 - 23.96 23.97 - 30.42 30.43 - 38.72 38.73 - 46.66 >= 46.67
Lung Cancer Reporting (Biopsy/Cytology Specimens) 395 Medicare Part B Claims -- -- -- -- 100      
Lung Cancer Reporting (Biopsy/Cytology Specimens) 395 MIPS CQM -- -- -- -- 100      
Lung Cancer Reporting (Resection Specimens) 396 Medicare Part B Claims -- -- -- -- 100      
Lung Cancer Reporting (Resection Specimens) 396 MIPS CQM -- -- -- -- 100      
Melanoma Reporting 397 Medicare Part B Claims -- -- -- -- 100      
Melanoma Reporting 397 MIPS CQM -- -- -- -- 100      
Optimal Asthma Control 398 MIPS CQM 33.33 - 49.28 49.29 - 58.04 58.05 - 80.13 80.14 - 99.99 -- -- -- 100
One-Time Screening for Hepatitis C Virus (HCV) for Patients at Risk 400 MIPS CQM 1.39 - 2.02 2.03 - 3.93 3.94 - 9.28 9.29 - 18.02 18.03 - 28.77 28.78 - 43.81 43.82 - 75.52 >= 75.53
Hepatitis C: Screening for Hepatocellular Carcinoma (HCC) in Patients with Cirrhosis 401 MIPS CQM -- -- -- -- -- -- -- --
Tobacco Use and Help with Quitting Among Adolescents 402 MIPS CQM 88.14 - 93.54 93.55 - 96.54 96.55 - 98.45 98.46 - 99.55 99.56-100      
Anesthesiology Smoking Abstinence 404 MIPS CQM 53.27 - 62.19 62.2 - 68.17 68.18 - 73.17 73.18 - 79.18 79.19 - 84.42 84.43 - 91.75 91.76 - 98.2 >= 98.21
Appropriate Follow-up Imaging for Incidental Abdominal Lesions 405 Medicare Part B Claims -- -- -- -- -- -- -- --
Appropriate Follow-up Imaging for Incidental Abdominal Lesions 405 MIPS CQM -- -- -- -- -- -- -- --
Appropriate Follow-up Imaging for Incidental Thyroid Nodules in Patients 406 Medicare Part B Claims 0.4 - 0.01 -- -- -- 0      
Appropriate Follow-up Imaging for Incidental Thyroid Nodules in Patients 406 MIPS CQM 2.27 - 0.01 -- -- -- 0      
Clinical Outcome Post Endovascular Stroke Treatment 409 MIPS CQM -- -- -- -- -- -- -- --
Psoriasis: Clinical Response to Systemic Medications 410 MIPS CQM 56.12 - 70.58 70.59 - 79.99 80.0 - 87.87 87.88 - 93.32 93.33 - 97.43 97.44 - 99.99 -- 100
Door to Puncture Time for Endovascular Stroke Treatment 413 MIPS CQM -- -- -- -- -- -- -- --
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older 415 MIPS CQM 83.73 - 90.9 90.91 - 94.43 94.44 - 96.39 96.4 - 97.55 97.56 - 98.54 98.55 - 99.41 99.42 - 99.99 100
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 Through 17 Years 416 MIPS CQM 27.21 - 20.01 20.0 - 12.13 12.12 - 5.89 5.88 - 3.46 3.45 - 2.05 2.04 - 0.01 -- 0
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 Through 17 Years 416 Medicare Part B Claims -- -- -- -- -- -- -- --
Osteoporosis Management in Women Who Had a Fracture 418 Medicare Part B Claims -- -- -- -- -- -- -- --
Osteoporosis Management in Women Who Had a Fracture 418 MIPS CQM -- -- -- -- -- -- -- --
Overuse of Imaging for the Evaluation of Primary Headache 419 MIPS CQM 28.52 - 16.36 16.35 - 10.44 10.43 - 5.36 5.35 - 3.24 3.23 - 1.63 1.62 - 0.21 0.2 - 0.01 0
Varicose Vein Treatment with Saphenous Ablation: Outcome Survey 420 MIPS CQM -- -- -- -- -- -- -- --
Appropriate Assessment of Retrievable Inferior Vena Cava (IVC) Filters for Removal 421 MIPS CQM -- -- -- -- -- -- -- --
Performing Cystoscopy at the Time of Hysterectomy for Pelvic Organ Prolapse to Detect Lower Urinary Tract Injury 422 MIPS CQM -- -- -- -- -- -- -- --
Performing Cystoscopy at the Time of Hysterectomy for Pelvic Organ Prolapse to Detect Lower Urinary Tract Injury 422 Medicare Part B Claims -- -- -- -- -- -- -- --
Perioperative Temperature Management 424 MIPS CQM 98.22 - 99.26 99.27 - 99.68 99.69 - 99.85 99.86 - 99.96 99.97 - 99.99 -- -- 100
Photodocumentation of Cecal Intubation 425 Medicare Part B Claims 98.8 - 99.43 99.44 - 99.99 -- -- -- -- -- 100
Photodocumentation of Cecal Intubation 425 MIPS CQM 89.1 - 94.77 94.78 - 96.72 96.73 - 97.95 97.96 - 98.55 98.56 - 99.12 99.13 - 99.47 99.48 - 99.94 >= 99.95
Pelvic Organ Prolapse: Preoperative Screening for Uterine Malignancy 429 Medicare Part B Claims -- -- -- -- -- -- -- --
Pelvic Organ Prolapse: Preoperative Screening for Uterine Malignancy 429 MIPS CQM -- -- -- -- -- -- -- --
Prevention of Post-Operative Nausea and Vomiting (PONV) - Combination Therapy 430 MIPS CQM 96.68 - 98.17 98.18 - 98.93 98.94 - 99.49 99.5 - 99.77 99.78-100      
Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling 431 MIPS CQM -- -- -- -- -- -- -- --
Proportion of Patients Sustaining a Bladder Injury at the Time of any Pelvic Organ Prolapse Repair 432 MIPS CQM -- -- -- -- -- -- -- --
Proportion of Patients Sustaining a Bowel Injury at the time of any Pelvic Organ Prolapse Repair 433 MIPS CQM -- -- -- -- -- -- -- --
Proportion of Patients Sustaining a Ureter Injury at the Time of Pelvic Organ Prolapse Repair 434 MIPS CQM -- -- -- -- -- -- -- --
Radiation Consideration for Adult CT: Utilization of Dose Lowering Techniques 436 Medicare Part B Claims 96.5 - 98.67 98.68 - 99.56 99.57 - 99.87 99.88 - 99.99 100      
Radiation Consideration for Adult CT: Utilization of Dose Lowering Techniques 436 MIPS CQM 98.96 - 99.76 99.77 - 99.96 99.97 - 99.99 -- 100      
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease 438 eCQM 62.47 - 66.21 66.22 - 68.96 68.97 - 71.36 71.37 - 73.74 73.75 - 76.07 76.08 - 79.56 79.57 - 83.32 >= 83.33
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease 438 MIPS CQM 67.31 - 73.02 73.03 - 76.49 76.5 - 82.39 82.4 - 87.43 87.44 - 93.09 93.1 - 99.99 -- 100
Age Appropriate Screening Colonoscopy 439 MIPS CQM -- -- -- -- -- -- -- --
Skin Cancer: Biopsy Reporting Time - Pathologist to Clinician 440 MIPS CQM 98.36 - 99.71 99.72 - 99.99 -- -- 100      
Ischemic Vascular Disease (IVD) All or None Outcome Measure (Optimal Control) 441 MIPS CQM 12.76 - 22.32 22.33 - 27.55 27.56 - 36.44 36.45 - 42.54 42.55 - 48.47 48.48 - 55.55 55.56 - 63.96 >= 63.97
Non-Recommended Cervical Cancer Screening in Adolescent Females 443 MIPS CQM -- -- -- -- -- -- -- --
Medication Management for People with Asthma 444 MIPS CQM -- -- -- -- -- -- -- --
Risk-Adjusted Operative Mortality for Coronary Artery Bypass Graft (CABG) 445 MIPS CQM 4.0 - 2.98 2.97 - 2.41 2.4 - 1.95 1.94 - 1.05 1.04 - 0.68 0.67 - 0.01 -- 0
Appropriate Workup Prior to Endometrial Ablation 448 MIPS CQM -- -- -- -- -- -- -- --
Trastuzumab Received By Patients With AJCC Stage I (T1c) - III And HER2 Positive Breast Cancer Receiving Adjuvant Chemotherapy 450 MIPS CQM -- -- -- -- -- -- -- --
RAS (KRAS and NRAS) Gene Mutation Testing Performed for Patients with Metastatic Colorectal Cancer who receive Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody Therapy 451 MIPS CQM -- -- -- -- -- -- -- --
Patients with Metastatic Colorectal Cancer and RAS (KRAS or NRAS) Gene Mutation Spared Treatment with Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibodies 452 MIPS CQM -- -- -- -- -- -- -- --
Percentage of Patients Who Died from Cancer Receiving Chemotherapy in the Last 14 Days of Life (lower score - better) 453 MIPS CQM 18.18 - 15.57 15.56 - 13.96 13.95 - 11.28 11.27 - 10.01 10.0 - 8.58 8.57 - 6.07 6.06 - 0.01 0
Percentage of Patients Who Died from Cancer Admitted to the Intensive Care Unit (ICU) in the Last 30 Days of Life (lower score - better) 455 MIPS CQM -- -- -- -- -- -- -- --
Percentage of Patients Who Died from Cancer Admitted to Hospice for Less than 3 days (lower score - better) 457 MIPS CQM 11.32 - 10.01 10.0 - 8.17 8.16 - 6.99 6.98 - 4.27 4.26 - 3.04 3.03 - 2.23 2.22 - 0.01 0
Back Pain After Lumbar Discectomy/Laminectomy 459 MIPS CQM -- -- -- -- -- -- -- --
Back Pain After Lumbar Fusion 460 MIPS CQM -- -- -- -- -- -- -- --
Leg Pain After Lumbar Discectomy/Laminectomy 461 MIPS CQM -- -- -- -- -- -- -- --
Bone Density Evaluation for Patients with Prostate Cancer and Receiving Androgen Deprivation Therapy 462 eCQM -- -- -- -- -- -- -- --
Prevention of Post-Operative Vomiting (POV) - Combination Therapy (Pediatrics) 463 MIPS CQM 94.59 - 97.29 97.3 - 98.24 98.25 - 99.07 99.08 - 99.66 99.67 - 100      
Otitis Media with Effusion: Systemic Antimicrobials - Avoidance of Inappropriate Use 464 MIPS CQM 84.47 - 87.52 87.53 - 89.99 90.0 - 92.74 92.75 - 94.53 94.54 - 96.14 96.15 - 97.59 97.6 - 99.99 100
Uterine Artery Embolization Technique: Documentation of Angiographic Endpoints and Interrogation of Ovarian Arteries 465 MIPS CQM -- -- -- -- -- -- -- --
Continuity of Pharmacotherapy for Opioid Use Disorder (OUD) 468 MIPS CQM -- -- -- -- -- -- -- --
Functional Status After Lumbar Fusion 469 MIPS CQM -- -- -- -- -- -- -- --
Functional Status After Primary Total Knee Replacement 470 MIPS CQM -- -- -- -- -- -- -- --
Functional Status After Lumbar Discectomy/Laminectomy 471 MIPS CQM -- -- -- -- -- -- -- --
Appropriate Use of DXA Scans in Women Under 65 Years Who Do Not Meet the Risk Factor Profile for Osteoporotic Fracture 472 eCQM -- -- -- -- -- -- -- 0
Leg Pain After Lumbar Fusion 473 MIPS CQM -- -- -- -- -- -- -- --
HIV Screening 475 eCQM 1.46 - 2.44 2.45 - 5.31 5.32 - 9.48 9.49 - 25.5 25.51 - 99.99 -- -- 100
International Prostate Symptom Score (IPSS) or American Urological Association-Symptom Index (AUA-SI) Change 6-12 Months After Diagnosis of Benign Prostatic Hyperplasia 476 eCQM -- -- -- -- -- -- -- --
Multimodal Pain Management 477 MIPS CQM -- -- -- -- -- -- -- --
Functional Status Change for Patients with Neck Impairments 478 MIPS CQM -- -- -- -- -- -- -- --